Skip to Main Content

Giles W. Robinson, MD

Member, St. Jude Faculty

Director, Division of Neuro-Oncology

Co-Leader, Cancer Center Neurobiology and Brain Tumor Program

On this page:

Contact Information

Giles W. Robinson, MD

Neuro Oncology

MS 260, Room C6069

St. Jude Children's Research Hospital

262 Danny Thomas Place

MemphisTN 38105-3678

Education

BA – Boston College, Chestnut Hill, Massachusetts MD – Brown Medical School, Providence, Rhode Island

Research Interests

  • Improve survival and reduce the morbidity of children with central nervous system tumors 
  • Genomic analysis of medulloblastoma and other central nervous system tumors
  • Tumor biology

Clinical Trials

Recruiting
SJ901: Study of Mirdametinib as a Treatment for Children, Adolescents and Young Adults with Low-Grade Glioma

Study goal:

The main goal of this study is to test the experimental drug mirdametinib in hopes of finding a treatment that may be effective against low-grade glioma brain tumors in children, adolescents and young adults.

Age:

At least 2 years old and younger than 25 years old.

Recruiting
SJiMB21: Risk-Based Medulloblastoma Treatment for Infants and Young Children

Study goal:

This study uses a risk-directed approach to find out which types of treatment will work best and have the fewest side effects for infants and children with medulloblastoma.

Age:

Birth to 5 years old

Dr. Robinson in Progress

Dr. Robinson in St. Jude News